Impact of matrix-assisted laser desorption ionization time-of-flight mass spectrometry on the clinical management of patients with Gram-Negative Bacteremia: A prospective observational study

Clinical Infectious Diseases

Volumn 56, Issue 8, 2013, Pages 1101-1107

  Clerc, Olivier ^a   Prod'Hom, Guy ^b   Vogne, Christelle ^b   Bizzini, Alain ^b   Calandra, Thierry ^a   Greub, Gilbert ^a,b  

^a Department of Medicine   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

clinical management; gram negative bacteremia; MALDI TOF MS

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; ENTEROBACTERIACEAE; FEMALE; GRAM NEGATIVE SEPSIS; GRAM STAINING; HUMAN; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; GENTIAN VIOLET; HUMANS; MALE; MIDDLE AGED; PHENAZINES; PROSPECTIVE STUDIES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84875645781     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis1204     Document Type: Article

References (20)

1. Greub G. MALDI-TOF mass spectrometry: the quantum leap. Clin Microbiol Infect 2010; 16:1603.
2. Bizzini A, Durussel C, Bille J, Greub G, Prod'hom G. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol 2010; 48:1549-54.
3. Bizzini A, Greub G. Matrix-assisted laser desorption ionization timeof- flight mass spectrometry, a revolution in clinical microbial identification. Clin Microbiol Infect 2010; 16:1614-9.
4. La Scola B, Raoult D. Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry. PLoS One 2009; 4:e8041.
5. Prod'hom G, Bizzini A, Durussel C, Bille J, Greub G. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for direct bacterial identification from positive blood culture pellets. J Clin Microbiol 2010; 48:1481-3.
6. Stevenson LG, Drake SK, Murray PR. Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2010; 48:444-7.
7. Seifert H. The clinical importance of microbiological findings in the diagnosis and management of bloodstream infections. Clin Infect Dis 2009; 48:S238-45.
8. Micek ST, Welch EC, Khan J, et al. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to gram-negative bacteria: a retrospective analysis. Antimicrob Agents Chemother 2010; 54:1742-8.
9. Munson EL, Diekema DJ, Beekmann SE, Chapin KC, Doern GV. Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J Clin Microbiol 2003; 41:495-7. (Pubitemid 36098632)
10. Vlek AL, Bonten MJ, Boel CH. Direct matrix-assisted laser desorption ionization time-of-flight mass spectrometry improves appropriateness of antibiotic treatment of bacteremia. PLoS One 2012; 7:e32589.
11. Hodiamont CJ, Gouliouris T, Rozemeijer W, et al. Direct identification of micro-organisms in positive blood cultures using MALDI-TOF MS: consequences for advice on antibiotic therapy. ECCMID 2012 London, poster 2322.
12. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-6. (Pubitemid 36444440)
13. Croxatto A, Prod'hom G, Greub G. Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol Rev 2012; 36:380-407.
14. Doern GV, Vautour R, Gaudet M, Levy B. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol 1994; 32:1757-62. (Pubitemid 24189570)
15. Barenfanger J, Drake C, Kacich G. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 1999; 37:1415-8. (Pubitemid 29187810)
16. Kerremans JJ, Verboom P, Stijnen T, et al. Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. J Antimicrob Chemother 2008; 61:428-35.
17. Bruins M, Oord H, Bloembergen P, et al. Lack of effect of shorter turnaround time of microbiological procedures on clinical outcomes: a randomised controlled trial among hospitalised patients in the Netherlands. Eur J Clin Microbiol Infect Dis 2005; 24:305-13. (Pubitemid 40897514)
18. Barenfanger J, Graham DR, Kolluri L, et al. Decreased mortality associated with prompt Gram staining of blood cultures. Am J Clin Pathol 2008; 130:870-6.
19. Leibovici L, Shraga I, Drucker M, et al. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244:379-86. (Pubitemid 28513125)
20. Drancourt M. Detection of microorganisms in blood specimens using matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a review. Clin Microbiol Infect 2010; 16:1620-5.